IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 72 filers reported holding IMMUNE DESIGN CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,962,720 | $16,016,000 | 6.52% |
Abingworth LLP | 197,300 | $1,610,000 | 1.69% |
NEXTHERA CAPITAL LP | 85,138 | $695,000 | 0.60% |
Cormorant Asset Management, LP | 432,990 | $3,533,000 | 0.50% |
SPHERA FUNDS MANAGEMENT LTD. | 153,000 | $1,248,000 | 0.32% |
TFS CAPITAL LLC | 102,685 | $838,000 | 0.15% |
RS INVESTMENT MANAGEMENT CO LLC | 1,227,595 | $10,017,000 | 0.10% |
Eventide Asset Management | 180,000 | $1,469,000 | 0.09% |
Focused Wealth Management, Inc | 15,868 | $129,000 | 0.06% |
Spark Investment Management LLC | 77,500 | $632,000 | 0.06% |